Engineering of tumor-resident dendritic cells through delivery of TriMix mRNA results in therapeutic anti-cancer immune responses

Sandra Van Lint, Daphné Benteyn, Carlo Heirman, Kris Thielemans, Karine Breckpot

Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

Original languageEnglish
Title of host publicationCIMT, Mainz, 14-16.05.2013
Publication statusPublished - 16 May 2013

Keywords

  • tumor
  • dendritic cells
  • trimix
  • mRNA
  • cancer
  • immune response

Cite this